Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada
Article in Journal of the Canadian Association of Gastroenterology (March 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Journal of the Canadian Association of Gastroenterology (March 2024)
Article in Rheumatology and Therapy (March 2024)
Article in F1000Research (December 2023)